Promotion of Influenza Vaccination in the Emergency Department
This three-group, prospective, cluster-randomized controlled trial compared two interventions with a control group in noncritically ill, adult patients in the emergency department who were not vaccinated for influenza in the current vaccine season. Implementation of influenza vaccine messaging platforms (video clips, printed materials and verbal scripts) improved a 30-day vaccine uptake among unvaccinated patients in the emergency department. Flu vaccine uptake tripled with simple promotion. Full Access: NEJM
Increase in Invasive Serogroup Y Meningococcal Disease in the United States
The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to alert healthcare clinicians to an increase in invasive meningococcal disease, mainly attributable to Neisseria meningitidis serogroup Y. In 2023, 422 cases were reported in the U.S., the highest annual number of cases reported since 2014. As of March 25, 2024, 143 cases have been reported to CDC for the current calendar year, an increase of 62 cases over the 81 reported as of this date in 2023. Full Access: CDC
Measles Cases Jump 51% in 1 Week, CDC Data Shows
CDC has confirmed 97 total cases in 17 states as of March 28. This tally is up from 64 cases a week prior and represents a 51.6% increase in confirmed cases. In 2023, the CDC reported just 58 total cases. There have been 7 outbreaks (defined as 3 or more related cases) reported in 2024, and 72% of cases (70 of 97) are outbreak-associated. For comparison, 4 outbreaks were reported during 2023 and 48% of cases (28 of 58) were outbreak-associated. Full Access: CDCÂ
Ceftriaxone-Resistant Gonorrhea — China, 2022
Gonorrhea remains prevalent worldwide. The prevalence of ceftriaxone resistance among gonococcal isolates in China nearly tripled since 2017, increasing from 2.9% to 8.1% in 2022; this rate is relatively high compared with that in other countries. First identified in Beijing in 2016, this resistant clone has become widely disseminated across various regions of China with its proportion among all resistant clones steadily increasing since 2016, highlighting the challenge associated with addressing gonococcal resistance. The increasing prevalence of ceftriaxone resistance in N. gonorrhoeae in China highlights a pressing public health concern. Effective diagnosis and treatment and appropriate management of sex partners are essential to protect the health of infected persons and prevent ongoing transmission of gonorrhea, including transmission of resistant strains. Full Access: CDC
